Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  non-Hodgkin lymphoma
Stage/Subtype:  non-Hodgkin lymphoma
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-8 of 8 for your search:
Start Over
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
Recombinant Flt3 Ligand, Poly-ICLC, and Radiation Therapy in Treating Patients with Untreated, Relapsed, or Refractory Low Grade B-Cell or Cutaneous T Cell Lymphoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 13-1347, NCI-2017-00655, NCT01976585
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 3 months to 21 years
Trial IDs: BP-004, NCI-2015-01890, NCT02065869
A Phase 1/2, Dose Escalation, Cohort Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ASN002-101, NCI-2015-01866, NCT02440685
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients with Non-Hodgkin Lymphoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MC1685, NCI-2017-00113, NCT03035331
Consolidation Therapy in Patients With Hematologic Malignancies
Status: Not yet active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: KiroVAX001, NCI-2017-01297, NCT02709993
Ibrutinib and Vaccine Therapies in Treating Patients with Asymptomatic, High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-15012, NCI-2015-00932, 2015C0098, NCT02518555
Vaccine Therapy in Treating Patients with Previously Treated Follicular Lymphoma
Status: Temporarily closed
Phase: Phase I
Type: Treatment
Age: 40 and over
Trial IDs: 06-275, NCI-2010-00094, NCT00487305
Start Over